(Q35104817)

6 August 2017

title

Blindness in patients with treated open-angle glaucoma (English)

1 reference

6 August 2017

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(02)01974-7

23 December 2023

1

Philip P. Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689894

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12689894

23 December 2023

publication date

1 April 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0161642002019747?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(02)01974-7

https://api.elsevier.com/content/article/PII:S0161642002019747?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(02)01974-7

23 December 2023

1 reference

6 August 2017

volume

110

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

726-733

1 reference

Number of people with glaucoma worldwide

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

The probability of blindness from open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

The variation and covariation of cup and disc diameters

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Correlation of visual field progression between eyes in patients with open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Use of pattern standard deviation instead of corrected pattern standard deviation in Anderson's criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Inter-subject variability and normal limits of the SITA Standard, SITA Fast, and the Humphrey Full Threshold computerized perimetry strategies, SITA STATPAC.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Glaucoma follow-up when converting from long to short perimetric threshold tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Clinical evaluation of SITA: a new family of perimetric testing strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Automated perimetry detects visual field loss before manual Goldmann perimetry.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

A Clinical Comparison of Three Computerized Automatic Perimeters in the Detection of Glaucoma Defects

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

A clinical comparison of visual field testing with a new automated perimeter, the Humphrey Field Analyzer, and the Goldmann perimeter

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Proportion of those with open-angle glaucoma who become blind.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Glaucoma care in Olmsted County, Minnesota, 1965-1980: filtering surgery and vision outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Blindness in glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Racial differences in the cause-specific prevalence of blindness in east Baltimore

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Prevalence of glaucoma in the west of Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

The Glaucoma Laser Trial (GLT): 6. Treatment group differences in visual field changes. Glaucoma Laser Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Argon laser therapy for open-angle glaucoma. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Transscleral neodymium:YAG thermal cyclophotocoagulation in refractory glaucoma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

5-fluorouracil and glaucoma filtering surgery. II. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

The importance of disc hemorrhage in the prognosis of chronic open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Why do some people go blind from glaucoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Progressive low-tension glaucoma: treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Prognostic factors in glaucomatous visual field loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Compliance with topical pilocarpine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

An analysis of referral routes and diagnostic accuracy in cases of suspected glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Blind registration and glaucoma simplex

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Blindness from Glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Deprivation and late presentation of glaucoma: case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901974-7

7 January 2021

The global impact of glaucoma

2

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(02)01974-7

Visual field constriction as a cause of blindness or visual impairment

23 December 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(02)01974-7

Clinical Experiences with the Use of an Automated Perimeter (Otopus) in the Diagnosis and Management of Patients With Glaucoma and Neurologic Diseases

23 December 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(02)01974-7

Ophthalmoscopic observation of the retinal nerve fiber layer

23 December 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(02)01974-7

A comparison of patient compliance in treated vs untreated ocular hypertension

23 December 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(02)01974-7

Blindness from glaucoma and the economics of prevention

23 December 2023

60

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(02)01974-7

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference